Clinical trials
Terminated Neoplasm Metastasis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeiGene | 3 |
| Novartis Pharmaceuticals | 2 |
| West China Hospital | 2 |
| Antengene (Hangzhou) Biologics Co., Ltd. | 1 |
| Ipsen | 1 |
| Jiangsu Simcere Pharmaceutical Co., Ltd. | 1 |
| Shanghai EpimAb Biotherapeutics Co., Ltd. | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 12 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Rectal Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
| Prostatic Neoplasms, Castration-Resistant | 1 |
| Recurrence | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.